Logo
Logo

About Rimegepant API

Product
  • Therapeutic CategoryCentral Nervous System (CNS)

  • CAS Number

    929046-33-3

  • API Technology

    Synthetic

  • Dose Form

    Oral Solid/Tablets

  • Dr Reddy's Development Status

    Under Development

Mechanism of Action

Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking CGRP receptors, which helps to reduce migraine symptoms by preventing the amplification and perpetuation of migraine pain

Indication

Xanomeline is indicated for the treatment of schizophrenia

Related APIs

Eslicarbazepine Acetate-es

Central Nervous System (CNS)

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone
Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.